Wordt geladen...
Observational research on sodium glucose co‐transporter‐2 inhibitors: A real breakthrough?
Sodium glucose co‐transporter‐2 inhibitors have attracted the interest of the scientific community following the results from dedicated cardiovascular outcome trials, which demonstrated remarkable reduction in all‐cause mortality and other cardiovascular (CV) endpoints with empagliflozin and canagli...
Bewaard in:
| Gepubliceerd in: | Diabetes Obes Metab |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Blackwell Publishing Ltd
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6283243/ https://ncbi.nlm.nih.gov/pubmed/30003655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13468 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|